May 31, 2023
Managing Directors John Schultz and Brennan Rittenhouse Featured in Global Life Sciences Podcast Series BioDech
Executive compensation plays a critical role in the success of any IPO. In the fifth episode of the BioDech global life sciences broadcast series, A&M's John Schultz and Brennan Rittenhouse speak with Dechert's Kevin Kay about key considerations such as market assessment, identification of peer groups, competitive research, regulatory considerations and more.